MarketBeat
07 Nov 2026, 07:19 UTC · 52m ago
What Cigna Group (CI) Said on Its Q3 Earnings Call
Impact · against what's priced in
Cigna's guidance raise and strong Healthcare segment performance provide a concrete catalyst for a stock that the market has previously refused to reward despite a series of beats. The confirmation of 10% growth for 2027 suggests a growth trajectory that contradicts the price's assumption of severe deceleration.
- CI+0.50
Challenges what's priced in
- The price assumes
Continued upward earnings revisions, as the price refuses to pay for a fifth consecutive beat or the raised $30.35 EPS guidance
The company raised its full-year adjusted EPS outlook to at least $30.60, continuing a trend of upward revisions that the market has explicitly declined to pay for.
What CI's price assumes · Sep 23
